Inequity in publicly funded physician care: What is the role of private prescription drug insurance?

Health Economics

Volumn 18, Issue 10, 2009, Pages 1218-1232

  Allin, Sara ^a   Hurley, Jeremiah ^b  

^a LONDON SCHOOL OF ECONOMICS   (United Kingdom)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Equity; Physician utilization; Prescription drugs; Private insurance

Indexed keywords

DRUG;

ADULT; ARTICLE; CANADA; DRUG COST; DRUG USE; FEMALE; FINANCIAL MANAGEMENT; GENERAL PRACTICE; GENERAL PRACTITIONER; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HEALTH SERVICE; HOSPITAL ADMISSION; HUMAN; MALE; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; FEMALE; FINANCING, GOVERNMENT; HUMANS; INSURANCE, PHARMACEUTICAL SERVICES; LINEAR MODELS; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; ONTARIO; PHARMACEUTICAL PREPARATIONS; PHYSICIANS; PRIVATE SECTOR; YOUNG ADULT;

EID: 70350766698     PISSN: 10579230     EISSN: 10991050     Source Type: Journal    
DOI: 10.1002/hec.1428     Document Type: Article

References (38)

1. Allin S. 2008. Does equity in healthcare use vary across Canadian provinces? Healthcare Policy 3(2): 83-99.
2. Anis AH, Guh DP, Lacaille D, Marra C, Rashidi A, Li X, Esdaile J. 2005. When patients have to pay a share of drug costs: effects on frequency of physician visits, hospital admissions and filling of prescriptions. Canadian Medical Association Journal 173(11): 1335-1340. (Pubitemid 41713056)
3. Applied Management in association with Fraser Group and Tristat Resources. 2000. Canadians' Access to Insurance for Prescription Medicines, vol.2. Health Canada: Ottawa.
4. Asada Y, Kephart G. 2007. Equity in health services use and intensity of use in Canada. BMC Health Services Research 7: 41. DOI: 10.1186/1472-6973-7-41. (Pubitemid 46449918)
5. Atherly A. 2001. Supplemental insurance: Medicare's accidental stepchild. Medical Care Research and Review 58(2): 131-161. (Pubitemid 32488470)
6. Buchmueller T, Couffinhal A, Grignon M, Perronnin M. 2004. Access to physician services: does supplemental insurance matter? Evidence from France. Health Economics 13: 669-687. (Pubitemid 39136259)
7. Buchmueller T, Grumbach K, Kronick R, Kahn JG. 2005. The effect of health insurance on medical care utilization and implications for insurance expansion: a review of the literature. Medical Research and Review 62(1): 3-30. (Pubitemid 41227378)
8. Chandra A, Gruber J, McKnight R. 2007. Patient cost-sharing, hospitalization offsets, and the design of optimal health insurance for the elderly. Working Paper No. 12972, National Bureau of Economic Research: Cambridge, MA.
9. Choudhry NK, Avorn J, Antman EM, Schneeweiss S, Shrank WH. 2007. Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis. Health Affairs 26: 186-194.
10. CIHI. 2007. National Health Expenditure Trends, 1975- 2007. Canadian Institute for Health Information: Ottawa; 20-21.
11. Curtis LJ, MacMinn WJ. 2007. Health-care utilization in Canada: 25 years of evidence. SEDAP Research Paper No. 190, The Program for Research on Social and Economic Dimensions of an Aging Population, McMaster University: Hamilton.
12. Deb P, Trivedi PK. 2006. Empirical Models of Health Care Use. In The Elgar Companion to Health Economics, Jones AJ (ed.). Edward Elgar: Cheltenham; 147-155.
13. Dewa CS, Hoch JS, Steele L. 2005. Prescription drug benefits and Canada's uninsured. International Journal of Law and Psychiatry 28: 496-513. (Pubitemid 41338402)
14. Flood CM, Archibald T. 2001. The illegality of private health care in Canada. Canadian Medical Association Journal 164(6): 825-830. (Pubitemid 32511046)
15. Grootendorst P, Newman EC, Levine M. 2003. Validity of self-reported prescription drug insurance coverage. Health Reports 14(2): 35-46.
16. Grossman M. 1972. On the concept of health capital and the demand for health. The Journal of Political Economy 80(2): 223-255.
17. Hurley J, Guindon E. 2008. Private health insurance in Canada. In Private health insurance and medical savings accounts: lessons from International experience, Thomson S, Mossialos E, Evans RG (eds), Cambridge: Cambridge University Press, forthcoming.
18. IMS Health. 2007. Pharmaceutical Trends: Top 10 Diagnoses in Canada, 2006. IMS Health: Canada.
19. Jiménez-Rubio D, Smith PC, van Doorslaer E. 2008. Equity in health and health care in a decentralised context: evidence from Canada. Health Economics 17: 377-392.
20. Jones AM, Koolman X, van Doorslaer E. 2007. The impact of having supplementary private health insurance on the use of specialists. Annales d'Économies et de Statistique 83/84: 1-25.
21. Kakwani N, Wagstaff A, van Doorslaer E. 1997. Socioeconomic inequality in health: measurement, computation and statistical inference. Journal of Econometrics 77(1): 87-104. (Pubitemid 127381047)
22. Kapur V, Basu U. 2005. Drug coverage in Canada: who is at risk? Health Policy 71: 181-193.
23. Kirby M. 2002. The Health of Canadians: the Federal Role, Chapter 7. The Standing Senate Committee on Social Affairs, Science and Technology: Ottawa.
24. Lewis K, Ellwood M, Czajka JL. 1998. Counting the uninsured: a review of the literature. Occasional Paper Number 8, The Urban Institute: Washington; 8.
25. O'Donnell O, van Doorslaer E, Wagstaff A, Liondelow M. 2008. Analyzing Health Equity Using Household Survey Data. The World Bank: Washington, DC.
26. OECD. 2007. OECD Health Data, 2007. Organisation for Economic Co-operation and Development: Paris.
27. Robinson R. 2002. User Charges for Health Care. In Funding Health Care: Options for Europe, Mossialos E, Dixon A, Figueras J, Kutzin J (eds). Open University Press: Buckingham; 161-183.
28. Romanow RJ. 2002. Building on Values: The Future of Health Care in Canada. Commission on the Future of Health Care in Canada: Ottawa; 189-210.
29. Shang B, Goldman DP. 2007. Prescription drug coverage and elderly Medicare spending. NBER Working Paper 13358, National Bureau of Economic Research: Cambridge, MA.
30. Soumerai S, Ross-Degnan D, Avorn J, McLaughlin T, Choodnovskiy I. 1991. Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes. New England Journal of Medicine 325: 1072-1077.
31. Stabile M. 2001. Private insurance subsidies and public health markets: evidence from Canada. Canadian Journal of Economics 34(4): 921-942. (Pubitemid 33720667)
32. van Doorslaer E, Clarke P, Savage E, Hall J. 2008. Horizontal inequities in Australia's mixed public/private health care system. Health Policy 86(1): 97-108. (Pubitemid 351297852)
33. van Doorslaer E, Masseria C, Koolman X. 2006. The OECD Health Equity Research Group. Inequalities in access to medical care by income in developed countries. Canadian Medical Association Journal 174(2): 177-183.
34. van Doorslaer E, Masseria C. 2004. OECD Health Equity Research Group Members. Income-related Inequality in the Use of Medical Care in 21 OECD Countries. OECD: Paris.
35. Wagstaff A, van Doorslaer E. 2000. Equity in Health Care Finance and Delivery. In Handbook of Health Economics, Culyer AJ, Newhouse JP (eds). North-Holland: Amsterdam; 1803-1862.
36. Wagstaff A, van Doorslaer E, Paci P. 1991. On the measurement of horizontal inequity in the delivery of health care. Journal of Health Economics 10: 169-205.
37. Wagstaff A, van Doorslaer, Watanabe N. 2003. On decomposing the causes of health sector inequalities with an application to malnutrition inequalities in Vietnam. Journal of Econometrics 112(1): 207-223.
38. Williamson DL, Fast JE. 1998. Poverty and medical treatment: when public policy compromises accessibility. Canadian Journal of Public Health 89(2): 120-124.